Font Size: a A A
Keyword [metastatic Colorectal Cancer]
Result: 21 - 40 | Page: 2 of 6
21. Retrospective Study On S-1Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin For First-line Treatment Of Patients With Metastatic Colorectal Cancer
22. The Influence Of Maintenance Therapy With Capecitabine For The Duration Of Diseases Control Of Metastatic Colorectal Cancer
23. The Association Of UGY1A1Polymorphism With The The Efficacy Of Irinotecan Chemotherapy On Advanced Colorectal Cancer And Its Adverse Reaction
24. The Clinical Efficacy Of FOLFOX4Combined With Bevacizumab Or Cetuximab In The First Line Treatment Of Metastatic Colorectal Cancer
25. The Explore VEGF Levels And Curative Effect In The Treatment Of Metastatic Colorectal Cancer With Bevacizumab
26. The Clinical Analysis Of Cetuximab Combined With FOLFOX4in The Treatment Of Metastatic Colorectal Cancer
27. The Clinical Efficacy Of Bevacizumab In The First-line Treatment Of Metastatic Colorectal Cancer
28. XELOX Versus FOLFOX As An Treatment For Metastatic Colorectal Cancer In Terms Of Efficacy And Safety: A Meta Analysis
29. Comparison Of Efficacy And Adverse Events Between Bevacizumab And Anti-EGFR Monoclonal Antibody In The Treatment For Metastatic Colorectal Cancer
30. Economic Evaluation Of Bevacizumab Combined With Chemotherapy As A Second-line Treatment For Metastatic Colorectal Cancer
31. Effect And Safety Of Cetuximab For The Treatment Of Metastatic Colorectal Cancer:a Meta Analysis
32. Research In Early Efficacy Of Patients With Potentially Resectable Metastatic Colorectal Cancer In Bevacizumab Therapy
33. Comparing Of Syndrome Classification In Traditional Chinese Medicine Of Common Gastrointestinal Side Effects From Chemotherapy Regimens Including Fluorouracil And Raltitrexed For Metastatic Colorectal Cancer
34. Effects Of Panitumumab Plus Chemoheraphy For The Metastatic Colorectal Cancer: A Meta Analysis
35. Chemotherapy Plus Combination Of Endostar And Thalidomide For Metastatic Colorectal Cancer
36. The Relevant Research Of Serum Angiogenensis Related Factor In The Detection Of Bevacizumab With Metastatic Colorectal Cancer
37. The Evidence-based Study Of Therapeutic Strategy To Treatment Metastatic Colorectal Cancer
38. Meta-Analysis Comparing Long-Term Efficacy Of Resection And Non-Resection For Primary Tumor In Patients With Metastatic Colorectal Cancer
39. Research On Function And Molecular Mechanism Of RaddeaninA In Inhibition Of Ocular Neovascularization
40. Cetuximab Plus Capecitabine Versus Capecitabine Alone In Elderly Patients With Previously Untreated Metastatic Colorectal Cancer
  <<First  <Prev  Next>  Last>>  Jump to